111 related articles for article (PubMed ID: 24909219)
1. A case of anti-BP180 type mucous membrane pemphigoid treated with intravenous immunoglobulin.
Aoki N; Nakajima K; Shiga T; Koga H; Hashimoto T; Sano S
J Dermatol; 2014 Jun; 41(6):557-9. PubMed ID: 24909219
[No Abstract] [Full Text] [Related]
2. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
[TBL] [Abstract][Full Text] [Related]
3. Anti-BP180-type oral mucous membrane pemphigoid reactive to both NC16a and C-terminal domains.
Uchiyama M; Mitsuhashi Y; Tsuboi R; Ishii N; Hayakawa T; Yasukochi A; Hashimoto T
Indian J Dermatol Venereol Leprol; 2015; 81(6):637-9. PubMed ID: 26515855
[No Abstract] [Full Text] [Related]
4. Acute blistering disease presenting IgG autoantibodies against NC16A and COOH-terminal domains of BP180 and laminin-332, with characteristic distribution of eruptions.
Kurashige Y; Minemura T; Nagatani T; Koga H; Hashimoto T
Eur J Dermatol; 2013; 23(1):109-10. PubMed ID: 23306276
[No Abstract] [Full Text] [Related]
5. Pure ocular mucous membrane pemphigoid reactive with both β4 integrin and the BP180 C-terminal domain.
Solano-López G; Concha-Garzón MJ; Sánchez-Pérez J; Hirako Y; Li X; Ishii N; Hashimoto T; Daudén E
Br J Dermatol; 2015 Feb; 172(2):542-4. PubMed ID: 25059542
[No Abstract] [Full Text] [Related]
6. Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180.
Daito J; Katoh N; Asai J; Ueda E; Takenaka H; Ishii N; Hashimoto T; Kishimoto S
Br J Dermatol; 2008 Sep; 159(4):984-6. PubMed ID: 18637895
[No Abstract] [Full Text] [Related]
7. Coexistence of pemphigus herpetiformis with IgG antibodies to desmocollin 1 and pemphigoid with IgG antibodies to BP180 C-terminal domain and laminin γ2.
Ohata C; Higashi Y; Yamagami J; Koga H; Ishii N; Kanekura T; Furumura M; Hashimoto T
JAMA Dermatol; 2013 Apr; 149(4):502-4. PubMed ID: 23715433
[No Abstract] [Full Text] [Related]
8. Brunsting-Perry-type cicatricial pemphigoid with IgG autoantibodies to LAD-1.
García-Martín P; Fraga J; Hashimoto T; García-Diez A
Br J Dermatol; 2014 Mar; 170(3):743-5. PubMed ID: 24124894
[No Abstract] [Full Text] [Related]
9. Study of original B cells producing pathogenic IgG and IgA autoantibodies in anti-BP180-type mucous membrane pemphigoid.
Hayashi D; Hashimoto T; Mine M; Ishii N; Hashimoto K; Tsuchisaka A; Tsuruta D
Arch Dermatol Res; 2024 May; 316(5):169. PubMed ID: 38734797
[No Abstract] [Full Text] [Related]
10. Detection of mucous membrane pemphigoid autoantibodies by full-length BP180 enzyme-linked immunosorbent assay.
Izumi K; Nishie W; Mai Y; Ujiie H; Iwata H; Natsuga K; Shimizu H
J Dermatol Sci; 2017 Nov; 88(2):247-248. PubMed ID: 28736219
[No Abstract] [Full Text] [Related]
11. Mucous membrane pemphigoid with IgG autoantibodies to the 120-kDa ectodomain of type XVII collagen (BP180/linear IgA dermatosis antigen) in a patient with idiopathic thrombocytopenic purpura.
Hirakawa Y; Oiso N; Ishii N; Koga H; Tatebayashi M; Uchida S; Matsuda H; Hashimoto T; Kawada A
Acta Derm Venereol; 2015 Apr; 95(4):493-4. PubMed ID: 25178495
[No Abstract] [Full Text] [Related]
12. [Mucous membrane pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
Bedane C; Prost C; Ingen-Housz-Oro S; Joly P; Bernard P;
Ann Dermatol Venereol; 2011 Mar; 138(3):259-63. PubMed ID: 21397156
[No Abstract] [Full Text] [Related]
13. Clinical and Immunological Studies of 332 Japanese Patients Tentatively Diagnosed as Anti-BP180-type Mucous Membrane Pemphigoid: A Novel BP180 C-terminal Domain Enzyme-linked Immunosorbent Assay.
Yasukochi A; Teye K; Ishii N; Hashimoto T
Acta Derm Venereol; 2016 Aug; 96(6):762-7. PubMed ID: 26984589
[TBL] [Abstract][Full Text] [Related]
14. IgA antibodies of cicatricial pemphigoid sera specifically react with C-terminus of BP180.
Nie Z; Hashimoto T
J Invest Dermatol; 1999 Feb; 112(2):254-5. PubMed ID: 9989805
[No Abstract] [Full Text] [Related]
15. Case of pemphigoid involving skin and mucous membrane with immunoglobulin G autoantibodies targeted to BP180 and laminin-332.
Hosoda S; Suzuki M; Komine M; Fujita E; Yamada T; Murata S; Koga H; Hashimoto T; Ohtsuki M
J Dermatol; 2013 Dec; 40(12):1067-8. PubMed ID: 24330181
[No Abstract] [Full Text] [Related]
16. Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid resolution with rituximab.
Huff SB; Vasu S; Kaffenberger BH
Int J Dermatol; 2019 Feb; 58(2):240-241. PubMed ID: 29707776
[No Abstract] [Full Text] [Related]
17. Cicatricial pemphigoid with circulating IgA and IgG autoantibodies to the central portion of the BP180 ectodomain: beneficial effect of adjuvant therapy with high-dose intravenous immunoglobulin.
Leverkus M; Georgi M; Nie Z; Hashimoto T; Bröcker EB; Zillikens D
J Am Acad Dermatol; 2002 Jan; 46(1):116-22. PubMed ID: 11756957
[TBL] [Abstract][Full Text] [Related]
18. Concurrent mucous membrane pemphigoid and membranous glomerulonephritis in a patient with autoantibodies targeting the 1080 region of collagen XVII.
Stump M; Messingham KN; Fairley JA
Br J Dermatol; 2019 Oct; 181(4):835-836. PubMed ID: 30916378
[No Abstract] [Full Text] [Related]
19. [Anti-p200/anti-laminin γ1 pemphigoid and BP180 NC16A/4575- positive mucous membrane pemphigoid : late diagnosis in a patient with disease-related loss of vision and multiple previous surgical interventions].
Kaune KM; Kasperkiewicz M; Tams D; Bergmann M; Zutt M
Hautarzt; 2015 Jan; 66(1):60-4. PubMed ID: 25339385
[TBL] [Abstract][Full Text] [Related]
20. Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.
Hayashi I; Shinkuma S; Shimizu S; Natsuga K; Ujiie H; Yasui C; Tsuchiya K; Nishie W; Shimizu H
Br J Dermatol; 2012 May; 166(5):1116-20. PubMed ID: 22182184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
